

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.01648213 |
| 2 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.71653366 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.52149661 |
| 4 | positive regulation of B cell differentiation (GO:0045579) | 4.45231591 |
| 5 | regulation of gamma-delta T cell activation (GO:0046643) | 4.14681645 |
| 6 | neutrophil activation involved in immune response (GO:0002283) | 4.14332661 |
| 7 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.11525112 |
| 8 | mast cell activation (GO:0045576) | 4.06671938 |
| 9 | negative thymic T cell selection (GO:0045060) | 4.05338506 |
| 10 | negative regulation of cell killing (GO:0031342) | 4.05188060 |
| 11 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.05188060 |
| 12 | negative T cell selection (GO:0043383) | 4.03194515 |
| 13 | positive regulation of granulocyte differentiation (GO:0030854) | 4.00359081 |
| 14 | cellular extravasation (GO:0045123) | 3.99190629 |
| 15 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.98742599 |
| 16 | positive thymic T cell selection (GO:0045059) | 3.96013154 |
| 17 | B cell receptor signaling pathway (GO:0050853) | 3.92815011 |
| 18 | T cell migration (GO:0072678) | 3.89174569 |
| 19 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.78720134 |
| 20 | negative regulation of interleukin-12 production (GO:0032695) | 3.77956569 |
| 21 | regulation of B cell differentiation (GO:0045577) | 3.77757536 |
| 22 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.65029102 |
| 23 | immunoglobulin mediated immune response (GO:0016064) | 3.61093812 |
| 24 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.59331537 |
| 25 | mast cell activation involved in immune response (GO:0002279) | 3.55688049 |
| 26 | mast cell degranulation (GO:0043303) | 3.55688049 |
| 27 | positive T cell selection (GO:0043368) | 3.52441081 |
| 28 | cellular response to interleukin-15 (GO:0071350) | 3.48306181 |
| 29 | myeloid cell activation involved in immune response (GO:0002275) | 3.45198480 |
| 30 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.44147454 |
| 31 | leukocyte degranulation (GO:0043299) | 3.41959005 |
| 32 | regulation of mast cell activation (GO:0033003) | 3.41704656 |
| 33 | positive regulation of mast cell activation (GO:0033005) | 3.34647362 |
| 34 | regulation of tolerance induction (GO:0002643) | 3.32864823 |
| 35 | response to peptidoglycan (GO:0032494) | 3.30729118 |
| 36 | neutrophil activation (GO:0042119) | 3.29289372 |
| 37 | negative regulation of B cell proliferation (GO:0030889) | 3.29224300 |
| 38 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.28139222 |
| 39 | negative regulation of T cell mediated immunity (GO:0002710) | 3.26458063 |
| 40 | response to interleukin-15 (GO:0070672) | 3.26221738 |
| 41 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.23009039 |
| 42 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.17777582 |
| 43 | regulation of T cell tolerance induction (GO:0002664) | 3.16923522 |
| 44 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.16609259 |
| 45 | interferon-gamma production (GO:0032609) | 3.15395912 |
| 46 | mature B cell differentiation involved in immune response (GO:0002313) | 3.13346748 |
| 47 | activated T cell proliferation (GO:0050798) | 3.12940941 |
| 48 | T cell selection (GO:0045058) | 3.12186645 |
| 49 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.12094988 |
| 50 | mature B cell differentiation (GO:0002335) | 3.09626170 |
| 51 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.06525345 |
| 52 | regulation of regulatory T cell differentiation (GO:0045589) | 3.04839158 |
| 53 | microglial cell activation (GO:0001774) | 3.03339890 |
| 54 | positive regulation of mast cell degranulation (GO:0043306) | 3.02047028 |
| 55 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.02047028 |
| 56 | regulation of mast cell degranulation (GO:0043304) | 3.01589894 |
| 57 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.99355448 |
| 58 | T cell costimulation (GO:0031295) | 2.98482308 |
| 59 | tolerance induction (GO:0002507) | 2.97864722 |
| 60 | granulocyte activation (GO:0036230) | 2.97798569 |
| 61 | positive regulation by symbiont of host defense response (GO:0052509) | 2.95825482 |
| 62 | modulation by symbiont of host defense response (GO:0052031) | 2.95825482 |
| 63 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.95825482 |
| 64 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.95825482 |
| 65 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.95825482 |
| 66 | modulation by symbiont of host immune response (GO:0052553) | 2.95825482 |
| 67 | lymphocyte costimulation (GO:0031294) | 2.94992971 |
| 68 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.94103342 |
| 69 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.93018338 |
| 70 | Peyers patch development (GO:0048541) | 2.92332663 |
| 71 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.92332663 |
| 72 | regulation of granulocyte differentiation (GO:0030852) | 2.91378669 |
| 73 | positive regulation of tolerance induction (GO:0002645) | 2.89857637 |
| 74 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.89811726 |
| 75 | regulation of hypersensitivity (GO:0002883) | 2.89421475 |
| 76 | macrophage activation involved in immune response (GO:0002281) | 2.88926990 |
| 77 | T cell receptor signaling pathway (GO:0050852) | 2.87434164 |
| 78 | detection of molecule of bacterial origin (GO:0032490) | 2.87265711 |
| 79 | B cell mediated immunity (GO:0019724) | 2.86312001 |
| 80 | regulation of B cell proliferation (GO:0030888) | 2.85598091 |
| 81 | detection of other organism (GO:0098543) | 2.83609757 |
| 82 | defense response to protozoan (GO:0042832) | 2.83246281 |
| 83 | regulation of alpha-beta T cell activation (GO:0046634) | 2.83151144 |
| 84 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.83139604 |
| 85 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.83110153 |
| 86 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.81898177 |
| 87 | response to host immune response (GO:0052572) | 2.81898177 |
| 88 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.81693686 |
| 89 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.81693686 |
| 90 | positive regulation of interleukin-2 production (GO:0032743) | 2.80478677 |
| 91 | thymic T cell selection (GO:0045061) | 2.80274006 |
| 92 | regulation of antigen processing and presentation (GO:0002577) | 2.80150165 |
| 93 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.79338325 |
| 94 | T cell proliferation (GO:0042098) | 2.78885417 |
| 95 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.78680295 |
| 96 | leukocyte aggregation (GO:0070486) | 2.78038664 |
| 97 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.76008338 |
| 98 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.75345242 |
| 99 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.74960485 |
| 100 | response to muramyl dipeptide (GO:0032495) | 2.72939217 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.48274375 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.74546087 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.55935840 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.28804223 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.21654967 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.22610980 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.15781792 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.03219399 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.90358958 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.81804297 |
| 11 | MYB_26560356_Chip-Seq_TH2_Human | 2.78206463 |
| 12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.73872881 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.73628219 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.58730616 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.52721954 |
| 16 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.43562135 |
| 17 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.43395656 |
| 18 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.33930952 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.23512046 |
| 20 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.14964948 |
| 21 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.11246044 |
| 22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.10381637 |
| 23 | GATA3_26560356_Chip-Seq_TH2_Human | 2.09424980 |
| 24 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.04477266 |
| 25 | MYB_26560356_Chip-Seq_TH1_Human | 2.00307679 |
| 26 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.00254023 |
| 27 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96926584 |
| 28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.90916914 |
| 29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89532978 |
| 30 | SPI1_23127762_ChIP-Seq_K562_Human | 1.70032221 |
| 31 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.69188716 |
| 32 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.67595966 |
| 33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.66718954 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.59509567 |
| 35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.57767134 |
| 36 | GATA1_22025678_ChIP-Seq_K562_Human | 1.53299571 |
| 37 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51047760 |
| 38 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.49175259 |
| 39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.46094384 |
| 40 | VDR_22108803_ChIP-Seq_LS180_Human | 1.44606665 |
| 41 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.43918652 |
| 42 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.42138338 |
| 43 | MAF_26560356_Chip-Seq_TH1_Human | 1.40664071 |
| 44 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.39186092 |
| 45 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.38434401 |
| 46 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.29834151 |
| 47 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29789621 |
| 48 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29444274 |
| 49 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.28438388 |
| 50 | UTX_26944678_Chip-Seq_JUKART_Human | 1.25401672 |
| 51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.24191038 |
| 52 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22981622 |
| 53 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.21908839 |
| 54 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.17932246 |
| 55 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16973564 |
| 56 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.14783614 |
| 57 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14652627 |
| 58 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13788353 |
| 59 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.13148969 |
| 60 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.07261664 |
| 61 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.03760221 |
| 62 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.03488723 |
| 63 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03467442 |
| 64 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.02637143 |
| 65 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.00952379 |
| 66 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.00761528 |
| 67 | MAF_26560356_Chip-Seq_TH2_Human | 0.99201762 |
| 68 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.97990289 |
| 69 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.97253856 |
| 70 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97088691 |
| 71 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97047416 |
| 72 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96341099 |
| 73 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.96234596 |
| 74 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95247603 |
| 75 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.94904898 |
| 76 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.94502910 |
| 77 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.92589444 |
| 78 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.90842872 |
| 79 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90324640 |
| 80 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89739362 |
| 81 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.87323782 |
| 82 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.87065669 |
| 83 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.87002078 |
| 84 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.84490612 |
| 85 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.83257516 |
| 86 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.81747479 |
| 87 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.80675424 |
| 88 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80124879 |
| 89 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.79264615 |
| 90 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.79263543 |
| 91 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.78838727 |
| 92 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.78838727 |
| 93 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.77994360 |
| 94 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.77404326 |
| 95 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.75468629 |
| 96 | * GATA3_26560356_Chip-Seq_TH1_Human | 0.75431758 |
| 97 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.74640663 |
| 98 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.74640663 |
| 99 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.74631131 |
| 100 | EWS_26573619_Chip-Seq_HEK293_Human | 0.73889879 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.25502388 |
| 2 | MP0005671_abnormal_response_to | 4.16917902 |
| 3 | MP0003724_increased_susceptibility_to | 3.93252992 |
| 4 | MP0005000_abnormal_immune_tolerance | 3.23828775 |
| 5 | MP0001800_abnormal_humoral_immune | 3.22665674 |
| 6 | MP0003436_decreased_susceptibility_to | 3.00817437 |
| 7 | MP0009785_altered_susceptibility_to | 2.98464987 |
| 8 | MP0003763_abnormal_thymus_physiology | 2.87867171 |
| 9 | MP0002723_abnormal_immune_serum | 2.68207730 |
| 10 | MP0002452_abnormal_antigen_presenting | 2.65214312 |
| 11 | MP0000685_abnormal_immune_system | 2.65178791 |
| 12 | MP0000569_abnormal_digit_pigmentation | 2.63143236 |
| 13 | MP0005387_immune_system_phenotype | 2.56873965 |
| 14 | MP0001790_abnormal_immune_system | 2.56873965 |
| 15 | MP0002420_abnormal_adaptive_immunity | 2.56625460 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 2.56433153 |
| 17 | MP0001819_abnormal_immune_cell | 2.54592587 |
| 18 | MP0002419_abnormal_innate_immunity | 2.54025195 |
| 19 | MP0005025_abnormal_response_to | 2.47439100 |
| 20 | MP0003303_peritoneal_inflammation | 2.36976017 |
| 21 | MP0009764_decreased_sensitivity_to | 2.12650787 |
| 22 | MP0005464_abnormal_platelet_physiology | 2.12105585 |
| 23 | MP0002398_abnormal_bone_marrow | 2.08953769 |
| 24 | MP0002405_respiratory_system_inflammati | 2.07929386 |
| 25 | MP0000716_abnormal_immune_system | 2.00470620 |
| 26 | MP0003828_pulmonary_edema | 1.99836315 |
| 27 | MP0006082_CNS_inflammation | 1.95777430 |
| 28 | MP0000689_abnormal_spleen_morphology | 1.87298555 |
| 29 | MP0001845_abnormal_inflammatory_respons | 1.74847331 |
| 30 | MP0009333_abnormal_splenocyte_physiolog | 1.71253229 |
| 31 | MP0002722_abnormal_immune_system | 1.71089633 |
| 32 | MP0001853_heart_inflammation | 1.68511294 |
| 33 | MP0002429_abnormal_blood_cell | 1.61457878 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.60712628 |
| 35 | MP0003656_abnormal_erythrocyte_physiolo | 1.57887543 |
| 36 | MP0005075_abnormal_melanosome_morpholog | 1.57823276 |
| 37 | MP0001533_abnormal_skeleton_physiology | 1.56780464 |
| 38 | MP0002132_abnormal_respiratory_system | 1.56485816 |
| 39 | MP0000465_gastrointestinal_hemorrhage | 1.56303498 |
| 40 | MP0003866_abnormal_defecation | 1.55429457 |
| 41 | MP0003183_abnormal_peptide_metabolism | 1.55343029 |
| 42 | MP0005084_abnormal_gallbladder_morpholo | 1.53828713 |
| 43 | MP0000703_abnormal_thymus_morphology | 1.52894086 |
| 44 | MP0009278_abnormal_bone_marrow | 1.44882126 |
| 45 | MP0002166_altered_tumor_susceptibility | 1.41697878 |
| 46 | MP0005310_abnormal_salivary_gland | 1.39252998 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.38616805 |
| 48 | MP0005397_hematopoietic_system_phenotyp | 1.38616805 |
| 49 | MP0008961_abnormal_basal_metabolism | 1.36220354 |
| 50 | MP0002396_abnormal_hematopoietic_system | 1.32355468 |
| 51 | MP0008469_abnormal_protein_level | 1.29903895 |
| 52 | MP0004947_skin_inflammation | 1.28141551 |
| 53 | MP0004381_abnormal_hair_follicle | 1.25906671 |
| 54 | MP0003300_gastrointestinal_ulcer | 1.22696042 |
| 55 | MP0009765_abnormal_xenobiotic_induced | 1.21752511 |
| 56 | MP0002138_abnormal_hepatobiliary_system | 1.17075021 |
| 57 | MP0004147_increased_porphyrin_level | 1.12022061 |
| 58 | MP0001986_abnormal_taste_sensitivity | 1.08785485 |
| 59 | MP0002009_preneoplasia | 1.07993348 |
| 60 | MP0009763_increased_sensitivity_to | 1.06002909 |
| 61 | MP0003172_abnormal_lysosome_physiology | 1.02967504 |
| 62 | MP0001851_eye_inflammation | 1.01351756 |
| 63 | MP0002822_catalepsy | 0.99891124 |
| 64 | MP0003191_abnormal_cellular_cholesterol | 0.99303944 |
| 65 | MP0002006_tumorigenesis | 0.98860735 |
| 66 | MP0005167_abnormal_blood-brain_barrier | 0.97108265 |
| 67 | MP0005410_abnormal_fertilization | 0.95958663 |
| 68 | MP0005174_abnormal_tail_pigmentation | 0.95940433 |
| 69 | MP0004808_abnormal_hematopoietic_stem | 0.95635681 |
| 70 | MP0004883_abnormal_blood_vessel | 0.94772662 |
| 71 | MP0008004_abnormal_stomach_pH | 0.94355073 |
| 72 | MP0000015_abnormal_ear_pigmentation | 0.93122983 |
| 73 | MP0002933_joint_inflammation | 0.88652600 |
| 74 | MP0003806_abnormal_nucleotide_metabolis | 0.87300110 |
| 75 | MP0002998_abnormal_bone_remodeling | 0.82437976 |
| 76 | MP0003045_fibrosis | 0.79993711 |
| 77 | MP0008877_abnormal_DNA_methylation | 0.77656365 |
| 78 | MP0006035_abnormal_mitochondrial_morpho | 0.77220000 |
| 79 | MP0005166_decreased_susceptibility_to | 0.77084574 |
| 80 | MP0000858_altered_metastatic_potential | 0.70966363 |
| 81 | MP0000249_abnormal_blood_vessel | 0.70853466 |
| 82 | MP0000343_altered_response_to | 0.69896275 |
| 83 | MP0001873_stomach_inflammation | 0.67173567 |
| 84 | MP0005164_abnormal_response_to | 0.66805681 |
| 85 | MP0008995_early_reproductive_senescence | 0.66733436 |
| 86 | MP0004484_altered_response_of | 0.64087528 |
| 87 | MP0008875_abnormal_xenobiotic_pharmacok | 0.63916606 |
| 88 | MP0001501_abnormal_sleep_pattern | 0.62679684 |
| 89 | MP0002019_abnormal_tumor_incidence | 0.62105003 |
| 90 | MP0003075_altered_response_to | 0.61622475 |
| 91 | MP0002136_abnormal_kidney_physiology | 0.61441671 |
| 92 | MP0006072_abnormal_retinal_apoptosis | 0.60863485 |
| 93 | MP0005390_skeleton_phenotype | 0.59767084 |
| 94 | MP0005365_abnormal_bile_salt | 0.59618494 |
| 95 | MP0001663_abnormal_digestive_system | 0.59538049 |
| 96 | MP0003252_abnormal_bile_duct | 0.59205564 |
| 97 | MP0003646_muscle_fatigue | 0.57641032 |
| 98 | MP0006054_spinal_hemorrhage | 0.57462562 |
| 99 | MP0002277_abnormal_respiratory_mucosa | 0.55410802 |
| 100 | MP0003787_abnormal_imprinting | 0.55401650 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.84550542 |
| 2 | Myositis (HP:0100614) | 4.41338281 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.23944845 |
| 4 | T lymphocytopenia (HP:0005403) | 4.10695854 |
| 5 | Optic neuritis (HP:0100653) | 4.07346395 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 4.07346395 |
| 7 | Recurrent abscess formation (HP:0002722) | 4.07125464 |
| 8 | Abnormality of T cell number (HP:0011839) | 3.96913942 |
| 9 | Recurrent fungal infections (HP:0002841) | 3.96561574 |
| 10 | Stomatitis (HP:0010280) | 3.89082458 |
| 11 | Panhypogammaglobulinemia (HP:0003139) | 3.77620544 |
| 12 | Recurrent cutaneous fungal infections (HP:0011370) | 3.76747926 |
| 13 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.76747926 |
| 14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.75692413 |
| 15 | Orchitis (HP:0100796) | 3.67424038 |
| 16 | Mediastinal lymphadenopathy (HP:0100721) | 3.62168598 |
| 17 | Meningitis (HP:0001287) | 3.54179755 |
| 18 | Recurrent viral infections (HP:0004429) | 3.52821326 |
| 19 | Vasculitis (HP:0002633) | 3.49617550 |
| 20 | Abnormality of T cells (HP:0002843) | 3.41913066 |
| 21 | Gastrointestinal infarctions (HP:0005244) | 3.40425190 |
| 22 | Encephalitis (HP:0002383) | 3.37300714 |
| 23 | IgG deficiency (HP:0004315) | 3.36580046 |
| 24 | Recurrent skin infections (HP:0001581) | 3.32426517 |
| 25 | Agammaglobulinemia (HP:0004432) | 3.31006421 |
| 26 | Autoimmune hemolytic anemia (HP:0001890) | 3.21364481 |
| 27 | Keratoconjunctivitis sicca (HP:0001097) | 3.14129105 |
| 28 | Eczematoid dermatitis (HP:0000976) | 3.11828085 |
| 29 | Obstructive lung disease (HP:0006536) | 3.05597302 |
| 30 | Chronic obstructive pulmonary disease (HP:0006510) | 3.05597302 |
| 31 | Abnormality of the prostate (HP:0008775) | 3.05333440 |
| 32 | Eosinophilia (HP:0001880) | 2.99544718 |
| 33 | Hemoptysis (HP:0002105) | 2.99375100 |
| 34 | Keratoconjunctivitis (HP:0001096) | 2.99307059 |
| 35 | Pulmonary infiltrates (HP:0002113) | 2.96221372 |
| 36 | Abnormality of B cell number (HP:0010975) | 2.92835762 |
| 37 | Abnormality of eosinophils (HP:0001879) | 2.91957289 |
| 38 | Leukocytosis (HP:0001974) | 2.91571566 |
| 39 | Granulocytopenia (HP:0001913) | 2.86774360 |
| 40 | IgM deficiency (HP:0002850) | 2.83526618 |
| 41 | Abnormality of glycolipid metabolism (HP:0010969) | 2.82300923 |
| 42 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.82300923 |
| 43 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.82300923 |
| 44 | Recurrent bronchitis (HP:0002837) | 2.81413128 |
| 45 | Pustule (HP:0200039) | 2.80925814 |
| 46 | Severe combined immunodeficiency (HP:0004430) | 2.80177514 |
| 47 | Abnormality of T cell physiology (HP:0011840) | 2.75553723 |
| 48 | Abnormality of macrophages (HP:0004311) | 2.71050487 |
| 49 | Colitis (HP:0002583) | 2.64199635 |
| 50 | Chest pain (HP:0100749) | 2.63568112 |
| 51 | Absent/shortened dynein arms (HP:0200106) | 2.61357159 |
| 52 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.61357159 |
| 53 | Epistaxis (HP:0000421) | 2.60249498 |
| 54 | Arterial thrombosis (HP:0004420) | 2.59456834 |
| 55 | Gangrene (HP:0100758) | 2.59227543 |
| 56 | Increased IgM level (HP:0003496) | 2.58887685 |
| 57 | Congenital, generalized hypertrichosis (HP:0004540) | 2.52807288 |
| 58 | Autoimmune thrombocytopenia (HP:0001973) | 2.48483900 |
| 59 | Thick nail (HP:0001805) | 2.47240784 |
| 60 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.45981349 |
| 61 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.45799129 |
| 62 | Inflammation of the large intestine (HP:0002037) | 2.44666009 |
| 63 | B lymphocytopenia (HP:0010976) | 2.44020297 |
| 64 | Prolonged bleeding time (HP:0003010) | 2.40437747 |
| 65 | Recurrent sinusitis (HP:0011108) | 2.34802160 |
| 66 | Chronic sinusitis (HP:0011109) | 2.30886896 |
| 67 | Pulmonary embolism (HP:0002204) | 2.26590012 |
| 68 | Polyneuropathy (HP:0001271) | 2.24598675 |
| 69 | Abnormality of the columella (HP:0009929) | 2.23467737 |
| 70 | Long foot (HP:0001833) | 2.22571435 |
| 71 | Abnormality of the pleura (HP:0002103) | 2.21212054 |
| 72 | Gastrointestinal inflammation (HP:0004386) | 2.20371272 |
| 73 | Thyroiditis (HP:0100646) | 2.17907787 |
| 74 | Joint swelling (HP:0001386) | 2.17756452 |
| 75 | Combined immunodeficiency (HP:0005387) | 2.17537814 |
| 76 | Spontaneous hematomas (HP:0007420) | 2.16709635 |
| 77 | Anorexia (HP:0002039) | 2.15575714 |
| 78 | Abnormality of male internal genitalia (HP:0000022) | 2.13734112 |
| 79 | Fatigue (HP:0012378) | 2.10226258 |
| 80 | Verrucae (HP:0200043) | 2.08540537 |
| 81 | Papilloma (HP:0012740) | 2.08540537 |
| 82 | Amaurosis fugax (HP:0100576) | 2.08457107 |
| 83 | Vertigo (HP:0002321) | 2.04793838 |
| 84 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.02410933 |
| 85 | Lymphopenia (HP:0001888) | 2.02131872 |
| 86 | Urticaria (HP:0001025) | 2.01149954 |
| 87 | Amyloidosis (HP:0011034) | 1.96777312 |
| 88 | Abnormality of iron homeostasis (HP:0011031) | 1.95542090 |
| 89 | Gingival bleeding (HP:0000225) | 1.95356378 |
| 90 | Stomach cancer (HP:0012126) | 1.93383113 |
| 91 | Keratitis (HP:0000491) | 1.93084024 |
| 92 | Glomerulopathy (HP:0100820) | 1.92864281 |
| 93 | Skin rash (HP:0000988) | 1.91961069 |
| 94 | Chronic diarrhea (HP:0002028) | 1.90219683 |
| 95 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88491571 |
| 96 | Bronchitis (HP:0012387) | 1.87955360 |
| 97 | Increased serum ferritin (HP:0003281) | 1.87865894 |
| 98 | IgA deficiency (HP:0002720) | 1.87798706 |
| 99 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.86969480 |
| 100 | Thrombocytosis (HP:0001894) | 1.86474371 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 6.08850082 |
| 2 | TXK | 4.24430848 |
| 3 | TAOK3 | 3.78676333 |
| 4 | MAP4K1 | 3.40683926 |
| 5 | BLK | 3.16899862 |
| 6 | BCKDK | 2.82692297 |
| 7 | FES | 2.39325664 |
| 8 | KIT | 2.36781292 |
| 9 | SYK | 2.35654598 |
| 10 | MAP3K14 | 2.32403024 |
| 11 | RIPK4 | 2.31593253 |
| 12 | BTK | 2.19415763 |
| 13 | GRK6 | 2.13629547 |
| 14 | JAK3 | 1.98975617 |
| 15 | TEC | 1.97761966 |
| 16 | ZAP70 | 1.86054864 |
| 17 | IKBKE | 1.85451770 |
| 18 | ITK | 1.81097321 |
| 19 | CSK | 1.71198992 |
| 20 | TYK2 | 1.70940699 |
| 21 | PINK1 | 1.70653500 |
| 22 | BMPR2 | 1.65299310 |
| 23 | IKBKB | 1.65257859 |
| 24 | LYN | 1.61187239 |
| 25 | ADRBK2 | 1.59683116 |
| 26 | TBK1 | 1.43366065 |
| 27 | MAP4K2 | 1.40469803 |
| 28 | JAK1 | 1.39215212 |
| 29 | LCK | 1.36465829 |
| 30 | MARK3 | 1.34617985 |
| 31 | CSF1R | 1.31170341 |
| 32 | HCK | 1.26582120 |
| 33 | GRK7 | 1.25824081 |
| 34 | TRPM7 | 1.21706919 |
| 35 | IRAK4 | 1.14987977 |
| 36 | TLK1 | 1.14889849 |
| 37 | FGR | 1.10080288 |
| 38 | MATK | 1.09747251 |
| 39 | PIK3CG | 1.03185098 |
| 40 | KDR | 0.98702837 |
| 41 | EIF2AK3 | 0.97122208 |
| 42 | PRKCQ | 0.94645439 |
| 43 | TESK2 | 0.92304163 |
| 44 | IRAK1 | 0.91932290 |
| 45 | MAP2K3 | 0.91810263 |
| 46 | FRK | 0.87743745 |
| 47 | ZAK | 0.84252577 |
| 48 | PIM1 | 0.82313431 |
| 49 | MAPK11 | 0.79642560 |
| 50 | CDK19 | 0.78175908 |
| 51 | TGFBR2 | 0.77270293 |
| 52 | TNK2 | 0.75595878 |
| 53 | JAK2 | 0.72457296 |
| 54 | MST4 | 0.67924582 |
| 55 | ACVR1B | 0.62037309 |
| 56 | IGF1R | 0.60753637 |
| 57 | MAPK12 | 0.60382972 |
| 58 | CHUK | 0.55864315 |
| 59 | CDK4 | 0.53026945 |
| 60 | MAP3K5 | 0.52091889 |
| 61 | VRK1 | 0.52007355 |
| 62 | MAP2K2 | 0.51976169 |
| 63 | ABL1 | 0.51928690 |
| 64 | EGFR | 0.50396646 |
| 65 | MAPK13 | 0.48660899 |
| 66 | EIF2AK2 | 0.40082552 |
| 67 | CLK1 | 0.39833733 |
| 68 | FYN | 0.39608981 |
| 69 | CDK6 | 0.38263128 |
| 70 | MAPK15 | 0.35763486 |
| 71 | PDK1 | 0.34661668 |
| 72 | RPS6KA5 | 0.34291573 |
| 73 | MAP3K1 | 0.33882787 |
| 74 | INSR | 0.33549043 |
| 75 | MAPK7 | 0.33245237 |
| 76 | NUAK1 | 0.33194973 |
| 77 | ADRBK1 | 0.33171033 |
| 78 | FLT3 | 0.33047375 |
| 79 | IRAK2 | 0.32507810 |
| 80 | CDK8 | 0.30416314 |
| 81 | GRK1 | 0.30250843 |
| 82 | RPS6KA4 | 0.29215054 |
| 83 | SGK2 | 0.28035520 |
| 84 | FGFR3 | 0.27843334 |
| 85 | MAPKAPK3 | 0.25964111 |
| 86 | IRAK3 | 0.25753851 |
| 87 | STK10 | 0.25738804 |
| 88 | MAP3K11 | 0.24936211 |
| 89 | OBSCN | 0.24654759 |
| 90 | ERBB2 | 0.24422848 |
| 91 | CAMK4 | 0.24238793 |
| 92 | HIPK2 | 0.24207202 |
| 93 | PTK2B | 0.22820621 |
| 94 | PRKD2 | 0.22676079 |
| 95 | TAOK1 | 0.22513540 |
| 96 | MAPK3 | 0.21521461 |
| 97 | ERBB3 | 0.17257244 |
| 98 | SIK2 | 0.16483829 |
| 99 | MAPK4 | 0.16151902 |
| 100 | MAP3K3 | 0.15828278 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.95596511 |
| 2 | Asthma_Homo sapiens_hsa05310 | 3.83262439 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.71952510 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.56225987 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.40236281 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.23881565 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.81686268 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.79890305 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.72834141 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.66964668 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.52670614 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.13796484 |
| 13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.09725477 |
| 14 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.08244489 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.03280361 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.95109330 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.94186362 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.85806902 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.85743480 |
| 20 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.75483450 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 1.67474707 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.65612433 |
| 23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.51002530 |
| 24 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.47675986 |
| 25 | Measles_Homo sapiens_hsa05162 | 1.43764294 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.40372574 |
| 27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.38932808 |
| 28 | Legionellosis_Homo sapiens_hsa05134 | 1.30954480 |
| 29 | Malaria_Homo sapiens_hsa05144 | 1.27600235 |
| 30 | Influenza A_Homo sapiens_hsa05164 | 1.24879782 |
| 31 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.20514854 |
| 32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.17392314 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.13973464 |
| 34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.10767850 |
| 35 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.09434403 |
| 36 | Platelet activation_Homo sapiens_hsa04611 | 1.06959778 |
| 37 | Phagosome_Homo sapiens_hsa04145 | 1.03368824 |
| 38 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.03284250 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.00533916 |
| 40 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.99493117 |
| 41 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.98857138 |
| 42 | Pertussis_Homo sapiens_hsa05133 | 0.92361695 |
| 43 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.91116549 |
| 44 | Other glycan degradation_Homo sapiens_hsa00511 | 0.84866705 |
| 45 | Apoptosis_Homo sapiens_hsa04210 | 0.81609820 |
| 46 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.80689624 |
| 47 | Hepatitis B_Homo sapiens_hsa05161 | 0.74612946 |
| 48 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.71489165 |
| 49 | Olfactory transduction_Homo sapiens_hsa04740 | 0.69271509 |
| 50 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.68116746 |
| 51 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.65794652 |
| 52 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.59973562 |
| 53 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.55439301 |
| 54 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.55125936 |
| 55 | Lysosome_Homo sapiens_hsa04142 | 0.54185250 |
| 56 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.53280133 |
| 57 | HTLV-I infection_Homo sapiens_hsa05166 | 0.52432442 |
| 58 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.52142267 |
| 59 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.50006650 |
| 60 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.48588343 |
| 61 | Shigellosis_Homo sapiens_hsa05131 | 0.48492523 |
| 62 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.47387607 |
| 63 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.46997815 |
| 64 | Phototransduction_Homo sapiens_hsa04744 | 0.43237559 |
| 65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.42822393 |
| 66 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.41795402 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39742217 |
| 68 | Salmonella infection_Homo sapiens_hsa05132 | 0.37779493 |
| 69 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35738019 |
| 70 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.33860517 |
| 71 | Salivary secretion_Homo sapiens_hsa04970 | 0.32762946 |
| 72 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.31932682 |
| 73 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.31798734 |
| 74 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.31461846 |
| 75 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.31063770 |
| 76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.30498111 |
| 77 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.30406246 |
| 78 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.29415342 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.29157165 |
| 80 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.29013359 |
| 81 | Hepatitis C_Homo sapiens_hsa05160 | 0.27511738 |
| 82 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.27237315 |
| 83 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27191053 |
| 84 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.25343645 |
| 85 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.21740295 |
| 86 | Renin secretion_Homo sapiens_hsa04924 | 0.20255094 |
| 87 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.18028492 |
| 88 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.17753215 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.16742531 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.15955145 |
| 91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.14817770 |
| 92 | Taste transduction_Homo sapiens_hsa04742 | 0.14546147 |
| 93 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.13839404 |
| 94 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.13600690 |
| 95 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.13048684 |
| 96 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.12998614 |
| 97 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.12971417 |
| 98 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.12833642 |
| 99 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.12568095 |
| 100 | Homologous recombination_Homo sapiens_hsa03440 | 0.11677244 |

